Braunstein Glenn D
Department of Medicine, Cedars-Sinai Medical Center-University of California, Los Angeles, School of Medicine, 90048, USA.
Am J Obstet Gynecol. 2002 Jul;187(1):217-24. doi: 10.1067/mob.2002.124284.
False-positive serum human chorionic gonadotropin results are estimated to occur in 1 in 10(3) to 1 in 10(4) tests. Most of these false-positive results are due to interference by non-human chorionic gonadotropin substances (especially human luteinizing hormone and anti-animal immunoglobulin antibodies) and the detection of pituitary human chorionic gonadotropin. The false-positive human chorionic gonadotropin measurements are characterized by serum levels that are generally <1000 mIU/mL, the absence of human chorionic gonadotropin in the urine, nonparallelism of the human chorionic gonadotropin levels in serial dilutions of the serum with the human chorionic gonadotropin standard, results that are not consistent with the clinical or operative findings, the absence of a substantial change in the serum levels over time or after therapy, and the finding of a negative result when an alternative type of human chorionic gonadotropin assay is used. An algorithm is presented to aid in the recognition of false-positive human chorionic gonadotropin results in patients.
据估计,血清人绒毛膜促性腺激素假阳性结果在每10³至10⁴次检测中会出现1例。这些假阳性结果大多是由于非人绒毛膜促性腺激素物质(尤其是人促黄体生成素和抗动物免疫球蛋白抗体)的干扰以及垂体人绒毛膜促性腺激素的检测所致。人绒毛膜促性腺激素假阳性检测结果的特征为:血清水平通常<1000 mIU/mL、尿液中无人绒毛膜促性腺激素、血清系列稀释后人绒毛膜促性腺激素水平与人绒毛膜促性腺激素标准不呈平行关系、结果与临床或手术发现不一致、血清水平随时间推移或治疗后无显著变化,以及使用另一种人绒毛膜促性腺激素检测方法时出现阴性结果。本文提出了一种算法,以帮助识别患者中人绒毛膜促性腺激素的假阳性结果。